麻豆传媒

In Advance of 68th AACC Annual Scientific Meeting & Clinical Lab Expo

Must RSVP for Teleconference Dial-in Number

News — Leading researchers will discuss the global impact and role of diagnostic testing for the Zika virus as well as how the timing of infection affects pregnancy and newborns at a media briefing in advance of the 68th AACC Annual Scientific Meeting & Clinical Lab Expo being held in Philadelphia, July 31鈥揂ugust 4.

WHO: Scheduled speakers include:

鈥� Randall Kinkaid, PhD, National Institute of Allergy and Infectious Diseases (NIAID)鈥� Stephen Lovell, PhD, U.S. Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH)鈥� Keith Pardee, PhD, University of Toronto

DISCUSSION TOPICS:

鈥� Zika in Infants and Pregnancy (ZIP) study: the largest, multi-country study examining the full scope of Zika virus infection in pregnancy and childbirth鈥� Using the U.S. FDA Emergency Use Authorization program to help accelerate diagnostic development and approval for Zika鈥� Development of a rapid, low-cost test for Zika virus鈥� Success and challenges involved in speeding up the process of diagnostic test development

WHEN: Thursday, July 28 at 2鈥�3 p.m. U.S. EASTERN TIMERSVP: Contact Caroline Eggers at [email protected] to receive call-in details. RELATED RESEARCH AT THE 68TH AACC ANNUAL SCIENTIFIC MEETING AT THE PENNSYLVANIA CONVENTION CENTER IN PHILADELPHIA:

鈥� A new diagnostic test developed in Brazil simultaneously detects Zika, chikungunya, and dengue viruses in patients. This test can dramatically shorten the amount of time it takes to detect and diagnose these diseases which present similar symptoms in patients. 鈥溾�� (B-053) 鈥� will be presented in on Thursday, August 4, 2016, 10:30 a.m. 鈥� 12 noon U.S. Eastern Time, Room 201AB.

鈥� Researchers confirmed the accuracy of a clinical laboratory-based test that can rapidly identify the presence of Zika virus in blood samples early in the course of the illness. 鈥溾��(叠-215)

鈥� Researchers at Emory University report on the accuracy of an 鈥渋n-house鈥� early detection test for Zika that can distinguish Zika from other similar diseases. 鈥溾��(叠-202)

鈥� Research shows that using urine samples increased the rate of molecular detection of Zika virus and should be considered when blood collection is difficult to be assessed. Testing this way may be of particular interest for pregnant women, possibly reflecting viral replication in fetal tissues. 鈥溾��(叠-108)

鈥� Results from specific molecular tests show that Brazil鈥檚 Midwest region has the highest prevalence of Zika virus infection followed by North region and Southeast region. However, the published data indicate that the Northeast is the most affected. This prevalence study could lead to a clearer indication of virus potential to spread and establish in the country. 鈥溾�� (B-086)

鈥� A new whole-control process for Zika virus will enable laboratories to validate diagnostic tests and train technicians. 鈥溾�� (B-105)

Unless noted otherwise, all scientific posters listed above will be presented at the convention center on Wednesday, August 3 from 9:30 a.m. 鈥� 5 p.m. in the Terrace Ballroom. Presenting authors will be in attendance from 12:30鈥�1:30 p.m.

About the 68th AACC Annual Scientific Meeting & Clinical Lab ExpoThe AACC Annual Scientific Meeting offers 5 days packed with opportunities to learn about exciting science from July 31鈥揂ugust 4. Plenary sessions feature the latest research on the use of and testing for cannabis, combating premature death due to preventable causes such as tobacco and alcohol, the development of an 鈥渋ntelligent鈥� surgical knife, programmable bio-nano-chips, and the epigenetic causes of disease.

At the AACC Clinical Lab Expo, more than 750 exhibitors will fill the show floor of Philadelphia鈥檚 Pennsylvania Convention Center, with displays of the latest diagnostic technology, including but not limited to mobile health, molecular diagnostics, mass spectrometry, point-of-care, and automation. About AACCDedicated to achieving better health through laboratory medicine, AACC brings together more than 50,000 clinical laboratory professionals, physicians, research scientists, and business leaders from around the world focused on clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of progressing laboratory science. Since 1948, AACC has worked to advance the common interests of the field, providing programs that advance scientific collaboration, knowledge, expertise, and innovation. For more information, visit .